Analyst Consensus ?
ConsensusHold30 ratings
Bullish1136.7%
Neutral1756.7%
Bearish26.6%
Fortive Corporation · FTV · FY2025 Q2 · Calendar Q3 2025
Fortive leans on recurring revenue as tariffs and demand weigh
The supplied analysis supports a cautiously constructive post-spin thesis: recurring revenue, software, innovation, and disciplined capital allocation provide operating support, but tariff exposure and uneven government and healthcare demand limit visibility.
Reported Before market openNYSETechnology
$17.07B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.58
Consensus $0.58
EPS surprise
-0.9%
Reported versus consensus
Reported revenue
$1.52B
Consensus $1.01B
Revenue surprise
+49.9%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-2.5%
Event window
SPY move
-0.1%
Same window
Abnormal move
-2.4%
Stock minus SPY
Volume
2.5×
Versus trailing sessions
Subsequent drift
-2.2%
Up to 20 sessions
FTVSPY benchmark
Ask FN2 about FTV FY2025 Q2
Transcript, numbers and history already loaded
Why did FTV fall 2.5% after missing EPS estimates in FY2025 Q2?What changed in FTV's guidance and outlook in FY2025 Q2?Give me the bull and bear case for FTV after FY2025 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Fortive completed the Ralliant spin-off ahead of schedule and described a post-spin business with about 50% recurring revenue. The company maintained full-year adjusted EPS guidance while emphasizing tariff uncertainty, government spending pressure, and healthcare reimbursement changes as key constraints.
Guidance delta
Maintained full-year adjusted EPS guidance of $2.50-$2.60; no change was identified in the supplied analysis.
Key takeaways
- The Ralliant spin-off is complete, leaving Fortive with a simpler structure and about 50% recurring revenue.
- Management highlighted recurring-revenue growth, software and AI enhancements, and disciplined capital allocation as the post-spin growth framework.
- Tariff uncertainty, constrained government spending, healthcare reimbursement changes, and demand volatility remain the main near-term risks.
Management priorities
- Execute the Fortive Accelerated strategy through innovation, commercial execution, and recurring-revenue growth.
- Pursue accretive bolt-on acquisitions with financial and strategic discipline.
- Use cash flow for leverage reduction, share repurchases, dividends, and selected M&A.
Follow FTV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$56.05Current
$50Low
$71.28Average
$90High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 19, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 3, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 12, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 4, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 1, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Feb 9, 2026 |
| Mizuho | Underperform | Outperform | Downgrade | Jan 5, 2026 |
| Baird | Outperform | Outperform | Maintain | Nov 4, 2025 |
| TD Cowen | Hold | Buy | Downgrade | Jul 15, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jul 1, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Sep 6, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Jan 2, 2024 |
| B of A Securities | Neutral | Buy | Downgrade | Oct 26, 2023 |
| UBS | Buy | Buy | Maintain | Oct 10, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 27, 2022 |
| Loop Capital | Buy | Buy | Maintain | Jul 19, 2022 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jun 2, 2022 |
| Rosenblatt | Neutral | Neutral | Maintain | May 4, 2021 |
| Bank of America | Buy | Buy | Maintain | Sep 5, 2019 |
| Gordon Haskett | Hold | Buy | Downgrade | Aug 5, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 26, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Oct 29, 2018 |
| Argus | Buy | Buy | Maintain | Aug 14, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Oct 27, 2017 |
| Stifel | Hold | Hold | Maintain | Oct 27, 2017 |
| Oppenheimer | Perform | Perform | Maintain | Jan 18, 2017 |
| Goldman Sachs | Neutral | Neutral | Maintain | Sep 29, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $56.05. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $63 | $57.8 | +12.4% | Oct 5, 2026 |
| Truist Financial | Analyst unavailable | $67 | $61.8 | +19.5% | Jul 2, 2026 |
| Morgan Stanley | Analyst unavailable | $59 | $60.59 | +5.3% | Jun 3, 2026 |
| Argus Research | John Eade | $68 | $60.79 | +21.3% | May 11, 2026 |
| Truist Financial | Analyst unavailable | $61 | $60.73 | +8.8% | May 4, 2026 |
| Truist Financial | Analyst unavailable | $56 | $60.38 | -0.1% | Apr 20, 2026 |
| Barclays | Analyst unavailable | $63 | $60.12 | +12.4% | Feb 9, 2026 |
| Seaport Global | Analyst unavailable | $70 | $60.24 | +24.9% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $65 | $60.13 | +16.0% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $51 | $55.39 | -9.0% | Jan 5, 2026 |
| Wells Fargo | Joseph O'Dea | $59 | $54.91 | +5.3% | Dec 22, 2025 |
| Robert W. Baird | Robert Mason | $58 | $50.14 | +3.5% | Nov 4, 2025 |
| Truist Financial | Analyst unavailable | $58 | $51.38 | +3.5% | Oct 30, 2025 |
| Seaport Global | Analyst unavailable | $66 | $52.44 | +17.8% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $56 | $50.34 | -0.1% | Oct 30, 2025 |
| Mizuho Securities | Brett Linzey | $54 | $48.69 | -3.7% | Oct 17, 2025 |
| Barclays | Julian Mitchell | $54 | $48.73 | -3.7% | Aug 14, 2025 |
| Truist Financial | Jamie Cook | $55 | $49.65 | -1.9% | Jul 31, 2025 |
| Stephens | Jeff Lick | $50 | $51.15 | -10.8% | Jul 15, 2025 |
| Barclays | Analyst unavailable | $85 | $75.93 | +51.7% | Mar 26, 2025 |
| Wells Fargo | Joseph O'Dea | $80 | $76.65 | +42.7% | Jan 7, 2025 |
| Truist Financial | Jamie Cook | $90 | $78.32 | +60.6% | Dec 19, 2024 |
| UBS | Amit Mehrotra | $84 | $68.88 | +49.9% | Nov 13, 2024 |
| Barclays | Julian Mitchell | $98 | $77.6 | +74.8% | Oct 2, 2024 |
| Morgan Stanley | Christopher Snyd | $89 | $72.8 | +58.8% | Sep 6, 2024 |
| Mizuho Securities | Brett Linzey | $90 | $72.8 | +60.6% | Sep 6, 2024 |
| Barclays | Julian Mitchell | $94 | $72.88 | +67.7% | Sep 5, 2024 |
| Raymond James | Brian Gesuale | $85 | $72.86 | +51.7% | Sep 5, 2024 |
| Robert W. Baird | Richard Eastman | $85 | $73.04 | +51.7% | Sep 5, 2024 |
| Seaport Global | Scott Graham | $88 | $70.44 | +57.0% | Jul 25, 2024 |
| RBC Capital | Deane Dray | $77 | $70.4 | +37.4% | Jul 25, 2024 |
| Barclays | Julian Mitchell | $93 | $72.64 | +65.9% | Jul 10, 2024 |
| Argus Research | John Eade | $85 | $77.06 | +51.7% | May 13, 2024 |
| Wells Fargo | Joseph O'Dea | $84 | $76.05 | +49.9% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $83 | $76.05 | +48.1% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $93 | $83.77 | +65.9% | Apr 4, 2024 |
| Truist Financial | Jamie Cook | $99 | $85.46 | +76.6% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $77 | $65.72 | +37.4% | Dec 9, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $59.95 | +30.2% | Oct 12, 2022 |
| Barclays | Julian Mitchell | $72 | $65.28 | +28.5% | Aug 4, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $64 | $63 | +14.2% | Jun 7, 2022 |
| Wells Fargo | Analyst unavailable | $65 | $58.33 | +16.0% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $65 | $58.56 | +16.0% | Apr 29, 2022 |
| Barclays | Julian Mitchell | $75 | $61.9 | +33.8% | Mar 18, 2022 |
| Robert W. Baird | Robert Mason CFA | $81 | $64.32 | +44.5% | Feb 4, 2022 |
| Mizuho Securities | Brett Linzey | $82 | $72.16 | +46.3% | Jan 19, 2022 |
| Vertical Research | Jeffrey Sprague | $82 | $73.49 | +46.3% | Jan 3, 2022 |
| Loop Capital Markets | Scott Graham | $90 | $78.5 | +60.6% | Nov 22, 2021 |
| Credit Suisse | John Walsh | $87 | $75.56 | +55.2% | Oct 29, 2021 |
| Wolfe Research | Nigel Coe | $84 | $70.24 | +49.9% | Jul 12, 2021 |
| UBS | Markus Mittermaier | $86 | $72.16 | +53.4% | May 6, 2021 |
Track every rating change on FTV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection.…
Historical context
All FTV earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the FTV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-08T13:50:42.131751+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-08T13:50:42.128902+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-08. For educational purposes only; not investment advice.